The global fight against cancer took a significant step forward in June 2025, as leading oncologists, researchers, and medical professionals from over 20 countries gathered in Seoul for the 8th International Medical Conference hosted by the International Virus Research Association (IVRA). Held at Seoul St. Mary’s Hospital under the sponsorship of Adipolabs, the event brought together approximately 300 international experts and domestic specialists to share cutting-edge advancements in cancer treatment, with a particular focus on hyperthermia-based therapies.
Central to the discussions was the growing body of evidence supporting radiofrequency ablation and regional hyperthermia as effective adjuncts to conventional cancer treatments. Professor Jang Hong-seok of the Department of Radiation Oncology at Seoul St. Mary’s Hospital, Catholic University of Korea, presented findings from a clinical study involving 40 patients with metastatic abdominal lymph node cancer. His research demonstrated that radiofrequency hyperthermia, when combined with radiation therapy, induced more effective tumor necrosis than radiation alone, highlighting its potential to improve outcomes in hard-to-treat malignancies.
The conference emphasized a multidisciplinary approach to oncology, integrating innovations from radiation therapy, immunotherapy, natural compounds, and traditional medicine. Sessions covered topics ranging from the role of hyperthermia in tumor treatment and immune response modulation to the use of sulforaphane—a naturally occurring compound found in cruciferous vegetables—as a promising adjuvant in cancer therapy. Experts from India, Singapore, and China shared insights on how regional hyperthermia can be applied to both malignant and benign conditions, although discussions on integrative care included perspectives from Korean traditional medicine practitioners at Ilsan Cha Hospital.
Beyond technical presentations, the event fostered dialogue on systemic challenges in cancer care. Panel discussions addressed the need for integrated medical approaches in managing pancreatic and breast cancer, with contributions from specialists at Nabisolution Oriental Hospital and Yeosan Myeongji Hospital. The overarching theme remained clear: while no single therapy offers a universal cure, combining evidence-based modalities—particularly those enhancing the body’s natural defenses and targeting tumor microenvironments—represents a tangible path toward more effective, personalized cancer treatment.
As the global cancer burden continues to rise, forums like the IVRA International Medical Conference play a vital role in translating scientific innovation into clinical practice. By uniting diverse expertise under a shared mission of advancing patient-centered care, such gatherings aid ensure that breakthroughs in hyperthermia, immunotherapy, and integrative oncology are not only studied but also implemented where they can make the most difference.